BTIG Research Initiates Coverage on IperionX (NASDAQ:IPX)

Analysts set a $40 price target, indicating potential upside of 82% from the stock's previous close.

Mar. 27, 2026 at 12:06pm

BTIG Research has initiated coverage on shares of IperionX (NASDAQ:IPX), a mineral technology company focused on the production and commercialization of high-purity titanium and zirconium products. The brokerage firm issued a "buy" rating on the stock and set a $40.00 price target, which would represent a potential upside of 81.98% from the stock's previous close.

Why it matters

The initiation of coverage by BTIG Research is a positive sign for IperionX, as it indicates that a respected Wall Street firm sees significant upside potential in the company's shares. The $40 price target suggests that the analysts believe IperionX's business model and growth prospects are undervalued by the market, which could attract more investor attention and drive the stock price higher.

The details

In its report, BTIG Research cited IperionX's proprietary processing technologies and its Stony Creek Project in Virginia as key factors behind the firm's bullish outlook. The analysts believe that IperionX's ability to supply high-purity titanium and zirconium products to industries like aerospace, defense, additive manufacturing, and batteries will be a significant growth driver for the company.

  • BTIG Research initiated coverage on IperionX on Friday, March 27, 2026.

The players

BTIG Research

A full-service global financial services firm that provides institutional trading, investment banking, research, and related brokerage services.

IperionX (NASDAQ:IPX)

A mineral technology company focused on the production and commercialization of high-purity titanium and zirconium products, with a key asset being the Stony Creek Project in Virginia.

Got photos? Submit your photos here. ›

The takeaway

The initiation of coverage by BTIG Research on IperionX is a positive development that highlights the firm's belief in the company's growth potential. The $40 price target suggests that the analysts see significant upside in the stock, which could attract more investor attention and drive the share price higher in the coming months.